Electrospray ionization mass spectrometry (ESI-MS) combined with 170 Da trial tags provides precise quantitative and structural characterization of research peptides. This analytical framework enables laboratories to verify amino acid sequence integrity, measure isobaric mass shifts, and evaluate compound stability in rigorous in vitro research settings.
Electrospray ionization mass spectrometry (ESI-MS) combined with 170 Da trial tags provides precise quantitative and structural characterization of research peptides. This analytical framework enables laboratories to verify amino acid sequence integrity, measure isobaric mass shifts, and evaluate compound stability in rigorous in vitro research settings.
Electrospray ionization mass spectrometry (ESI-MS) is a foundational analytical technique used to determine the molecular weight, structural stoichiometry, and sequence fidelity of synthesized research peptides. Unlike hard ionization techniques that cause extensive molecular fragmentation, ESI operates as a soft ionization method. It transfers intact peptide ions from liquid phase into gas phase under high voltage, generating multicharged species ([M+nH]n+) ideally suited for high-resolution quadrupoles, time-of-flight (TOF), or Orbitrap mass analyzers.
When combined with a 170 Da trial tag—a specialized chemical modification or isobaric mass tag engineered to yield a diagnostic reporter ion at 170 m/z upon collision-induced dissociation (CID)—investigators gain enhanced capacity for relative multiplexed quantification and targeted structural profiling. In routine analytical protocols, these mass tags covalently bond to primary amine groups (such as N-termini or lysine side chains) within the target peptide sequence, yielding a distinct mass shift detectable via high-performance analytical systems.
Isobaric mass tagging reagents generally consist of three structural regions: an amine-reactive functional group (such as an N-hydroxysuccinimide ester), a balance region, and a reporter tag region. In the specific case of 170 Da reporter tags, the chemical architecture is designed so that during tandem mass spectrometry (MS/MS), higher-energy collisional dissociation (HCD) cleaves the weak amide linkage between the balance region and the reporter group.
This controlled cleavage releases the distinct 170.1 Da reporter ion, whose signal intensity directly corresponds to the abundance of the labeled peptide in a given sample mixture. Preclinical and analytical studies indicate that 170 Da trial tags maintain high ionization efficiency under positive-mode ESI conditions, minimizing charge-state suppression while facilitating precise relative quantification across multi-sample laboratory comparisons.
In analytical proteomic workflows and in vitro peptide assays, 170 Da mass tags are deployed to track candidate research compounds across complex enzymatic assays, serum-stability models, and binding affinity experiments. By incorporating a precise 170 Da modification, researchers can multiplex control and experimental samples into a single ESI-MS run, dramatically reducing instrument time and eliminating run-to-run retention time variance.
Preclinical data suggest that utilizing standardized trial tags allows research teams to measure micro-environmental peptide degradation, cleavage kinetics, and post-translational modifications with high fidelity. Researchers exploring broad peptide analytical libraries often reference our comprehensive guide on isobaric mass tagging in proteomics to optimize labeling efficiency and sample preparation strategies prior to ESI-MS acquisition.
Characterizing custom peptides using ESI-MS requires systematic interpretation of the charge envelope and deconvoluted mass spectrum. Because ESI produces multiple protonation states, an unlabeled or tagged peptide exhibits a distribution of peaks corresponding to [M+H]+, [M+2H]2+, and [M+3H]3+ species. Evaluating the baseline noise and peak resolution ensures that side-products—such as truncated sequences, incomplete deprotection artifacts, or oxidation peaks—are accurately quantified.
To confirm compound purity, ESI-MS data must be cross-referenced with Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) chromatograms. While HPLC separates chemical species based on hydrophobicity, ESI-MS confirms exact molecular weight. Laboratories seeking to establish strict analytical quality protocols can review our resource on peptide purity HPLC mass spectrometry guide for detailed spectrum deconvolutions and purity thresholds.
Selecting the appropriate mass labeling strategy depends heavily on instrument resolution, required multiplex capacity, and target peptide composition. Standard isobaric tagging platforms utilize reporter ions ranging from 113 Da to 131 Da, or custom tags extending to 170 Da and beyond. The 170 Da reporter tag offers specific advantages in complex spectral backgrounds, as its higher m/z location typically falls outside the dense region of low-mass matrix interference common to biological buffers.
When comparing mass tagging approaches across standard reference compounds, such as synthetic variants of BPC-157, TB-500, or custom sequence fragments, 170 Da trial tags demonstrate stable signal fragmentation without compromising overall peptide solubility. Unlike bulky fluorescent labels (e.g., FITC or Rhodamine) which can alter physical dimensions and hydrophobic interaction profiles, the compact chemical footprint of a 170 Da tag minimizes steric alteration during in vitro binding assays.
Achieving optimal ESI-MS signal clarity requires strict adherence to volatile solvent systems. Non-volatile salts, detergents, and classical physiological buffers (such as PBS, tris, or SDS) suppress ionization and form adduct ions (e.g., [M+Na]+, [M+K]+) that obscure theoretical peak masses. Peptides labeled with 170 Da trial tags should be reconstituted using MS-grade solvents, typically sterile deionized water combined with 0.1% formic acid or LC-MS grade acetonitrile.
For laboratory preparations, compounds must be fully dissolved and filtered through a 0.22 µm PTFE or PVDF membrane to remove particulate matter before injection into the autosampler. If non-volatile reagents were utilized during preceding enzymatic steps, solid-phase extraction (SPE) C18 zip-tips or desalting columns must be employed prior to mass spec analysis to ensure pristine ESI ionization efficiency.
In analytical peptide research, batch-to-batch consistency and raw material purity are essential for reproducible mass spectrometry results. PX1 Research adheres to rigorous manufacturing and testing protocols to ensure all research peptides meet exact analytical specifications before distribution to academic and corporate laboratories.
Every production lot undergoes third-party verification in an ISO 17025 accredited laboratory. Quality metrics include RP-HPLC analysis demonstrating ≥98% chemical purity, ESI-MS spectrum verification confirming exact theoretical molecular weight, and chromogenic LAL assays ensuring endotoxin levels remain below 0.01 EU/mg. Investigators evaluating critical research materials can browse our full catalog of all peptides or inspect specific product documentation via our esi mass spec trial tags 170 product page.
To maintain chemical stability and prevent pre-analytical degradation, lyophilized peptides tagged with 170 Da reagents must be stored in specialized laboratory conditions. Upon delivery, unopened vials should be maintained at -20°C or -80°C in a desiccated environment to prevent moisture condensation on the glass inner walls.
Once reconstituted in volatile aqueous solutions, aliquots should be used immediately or stored at -80°C to minimize hydrolytic cleavage or ester hydrolysis of the tag. Freeze-thaw cycles must be strictly avoided; repeated thermal cycling leads to peptide aggregation and potential loss of the 170 Da tag reporter group efficiency during subsequent MS/MS fragmentation runs.
High-throughput proteomics and quantitative ESI-MS experiments require absolute confidence in vendor sourcing. Substandard synthetic peptides frequently harbor racemized amino acids, incomplete deprotection sequences, or residual TFA salts that confound analytical interpretation and distort 170 Da reporter tag ratios.
PX1 Research manufactures all research compounds within state-of-the-art, GMP-compliant facilities located in the United States. Utilizing advanced automated solid-phase peptide synthesis (SPPS) and rigorous purification cascades, PX1 provides researchers with stable, fully characterized compounds supported by transparent lot-specific documentation. Investigators managing large-scale screening initiatives can explore dedicated options via our wholesale lab account portal or review analytical validation studies in our central research library.
What is the primary function of a 170 Da trial tag in ESI mass spectrometry?
A 170 Da trial tag acts as an isobaric or mass-adjusting label covalently attached to research peptides. Upon collision-induced dissociation (CID) or higher-energy collisional dissociation (HCD) in ESI-MS/MS, it cleaves to yield a predictable 170.1 m/z reporter ion used for precise relative quantification and structural identification.
Why is Electrospray Ionization (ESI) preferred over MALDI for tagged peptide characterization?
ESI is a soft ionization technique compatible with direct liquid chromatography inlet systems (LC-MS). It generates multi-charged ions, allowing high-molecular-weight tagged peptides to be analyzed within the standard m/z range of benchtop mass spectrometers while preserving delicate non-covalent or covalent tag modifications.
What solvents should be used to prepare 170 Da tagged peptides for ESI-MS?
Peptides intended for ESI-MS analysis should be reconstituted in volatile solvent mixtures such as LC-MS grade water, acetonitrile, and 0.1% formic acid. Avoid non-volatile salts (like NaCl or phosphate buffers) and non-volatile detergents, as they cause severe ion suppression and adduct formation.
How does PX1 Research verify the purity of peptides containing mass tags?
PX1 Research subjects every batch to independent third-party analytical testing in ISO 17025 accredited facilities. Purity is validated via RP-HPLC (verifying ≥98% purity) and identity is confirmed via high-resolution ESI-MS. Additionally, endotoxin testing ensures levels remain <0.01 EU/mg.
Can 170 Da tagged peptides be used for in vivo administration?
No. All compounds provided by PX1 Research, including tagged peptides and analytical trial reagents, are strictly for laboratory research use only (in vitro and preclinical evaluation). They are not for human or animal clinical use, therapeutic administration, or diagnostic procedures.
What is the recommended storage condition for lyophilized tagged research peptides?
Lyophilized research peptides should be stored sealed at -20°C or -80°C in a desiccated environment protected from light. Reconstituted solutions should be divided into single-use aliquots and stored at -80°C to avoid degradation from repeated freeze-thaw cycles.
How does a 170 Da tag differ from traditional fluorophore labels in physical behavior?
Unlike bulky fluorophores (e.g., FITC) which can alter hydrophobic properties, steric conformation, and solution behavior, 170 Da mass tags have a low molecular weight and minimal chemical footprint, preserving the native structural kinetics of the research peptide during assay conditions.
Where can researchers obtain lot-specific Certificate of Analysis (COA) documentation?
Every product shipment from PX1 Research includes access to a lot-specific COA containing full RP-HPLC chromatograms, ESI-MS spectra, and endotoxin assay results. COAs can also be requested directly through the PX1 Research online portal.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.